Low Fecal Elastase-1: A Non-negligible Factor in Functional Dyspepsia Patients
Digestive Diseases and Sciences · 2026
DOI: 10.1007/s10620-025-09500-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Digestive Diseases and Sciences, 2026. Verfasst von Jiao Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, West China Hospital, Sichuan University, No. 37, Guo Xue Alley, Wu Hou Distinct, Chengdu, 610041, Sich…. Hauptthemen laut MEDLINE: Dyspepsia, Feces, Pancreatic Elastase, Exocrine Pancreatic Insufficiency. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: West China hospital of Sichuan university, Chengdu Municipal Science and Technology Program.
Abstract (Originalsprache)
BACKGROUND AND AIM: Functional dyspepsia (FD) is one of the most prevalent functional gastrointestinal disorders. The occurrence of dyspepsia has been reported to be associated with a deficiency or dysfunction of digestive enzymes. Although the pancreas plays a critical role in secreting digestive enzymes, the relationship between FD and pancreatic exocrine insufficiency (PEI) remains unclear. This study aims to evaluate the prevalence of low Fecal elastase-1 (FE-1) level, a recognized indicator of PEI, in FD patients and explore potential risk factors contributing to this condition. METHODS: This cross-sectional study enrolled 76 FD patients. The FE-1 level was measured using a commercial ELISA kit. An FE-1 level below 200 μg/g stool was defined as abnormal. Clinical characteristics and gut microbiota composition were compared between FD patients with low FE-1 level (FE-L) and those with normal FE-1 level (FE-N). Logistic regression analysis was used to identify independent risk factors for low FE-1 level in FD patients. RESULTS: The prevalence of low FE-1 level among FD patients was 19.7%. Compared to the FE-N group, the FE-L group exhibited higher gastrointestinal symptoms scores, anxiety scores and lower quality of life scores (P 3, P < 0.05). CONCLUSIONS: The present study suggests that a subset of patients with FD have FE-1 secretion insufficiency and might benefit from pancreatic enzyme supplementation therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, West China Hospital, Sichuan University, No. 37, Guo Xue Alley, Wu Hou Distinct, Chengdu, 610041, Sichuan, China.
- Department of Gastroenterology and Hepatology, West China Hospital, Sichuan University, No. 37, Guo Xue Alley, Wu Hou Distinct, Chengdu, 610041, Sichuan, China. lingzipurple@163.com.
Förderung
- West China hospital of Sichuan university
- Chengdu Municipal Science and Technology Program
Zitieren
APA
Liu, J., He, T., Ji, L., & Liu, L. (2026). Low Fecal Elastase-1: A Non-negligible Factor in Functional Dyspepsia Patients. Digestive Diseases and Sciences. https://doi.org/10.1007/s10620-025-09500-2
Vancouver
Liu J, He T, Ji L, Liu L. Low Fecal Elastase-1: A Non-negligible Factor in Functional Dyspepsia Patients. Digestive Diseases and Sciences. 2026. doi:10.1007/s10620-025-09500-2
BibTeX
@article{Liu2026,
author = {Liu, Jiao and He, Tian and Ji, Linglong and Liu, Ling},
title = {Low Fecal Elastase-1: A Non-negligible Factor in Functional Dyspepsia Patients},
journal = {Digestive Diseases and Sciences},
year = {2026},
doi = {10.1007/s10620-025-09500-2}
}
EUVIMED